_version_ 1785090451683934208
author Haddad, Fadi
Jabbour, Elias
Zoghbi, Marianne
Short, Nicholas
Nasnas, Cedric
Nasr, Lewis
Macaron, Walid
Jain, Nitin
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan
Daver, Naval
Chien, Kelly
Alvarado, Yesid
Garcia-Manero, Guillermo
Issa, Ghayas
Kwari, Monica
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Rivera, Juan
Milton, Anna
Waller, Lourdes
Banks, Glenda
Garris, Rebecca
Ravandi, Farhad
Kantarjian, Hagop
author_facet Haddad, Fadi
Jabbour, Elias
Zoghbi, Marianne
Short, Nicholas
Nasnas, Cedric
Nasr, Lewis
Macaron, Walid
Jain, Nitin
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan
Daver, Naval
Chien, Kelly
Alvarado, Yesid
Garcia-Manero, Guillermo
Issa, Ghayas
Kwari, Monica
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Rivera, Juan
Milton, Anna
Waller, Lourdes
Banks, Glenda
Garris, Rebecca
Ravandi, Farhad
Kantarjian, Hagop
author_sort Haddad, Fadi
collection PubMed
description
format Online
Article
Text
id pubmed-10428366
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283662023-08-17 P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL Haddad, Fadi Jabbour, Elias Zoghbi, Marianne Short, Nicholas Nasnas, Cedric Nasr, Lewis Macaron, Walid Jain, Nitin Huang, Xuelin Montalban-Bravo, Guillermo Kadia, Tapan Daver, Naval Chien, Kelly Alvarado, Yesid Garcia-Manero, Guillermo Issa, Ghayas Kwari, Monica Delumpa, Ricardo Mayor, Ejiroghene Deen, Wuliamatu Thankachan, Jennifer Loiselle, Christopher Rivera, Juan Milton, Anna Waller, Lourdes Banks, Glenda Garris, Rebecca Ravandi, Farhad Kantarjian, Hagop Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428366/ http://dx.doi.org/10.1097/01.HS9.0000968428.69134.08 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Haddad, Fadi
Jabbour, Elias
Zoghbi, Marianne
Short, Nicholas
Nasnas, Cedric
Nasr, Lewis
Macaron, Walid
Jain, Nitin
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan
Daver, Naval
Chien, Kelly
Alvarado, Yesid
Garcia-Manero, Guillermo
Issa, Ghayas
Kwari, Monica
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Rivera, Juan
Milton, Anna
Waller, Lourdes
Banks, Glenda
Garris, Rebecca
Ravandi, Farhad
Kantarjian, Hagop
P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL
title P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL
title_full P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL
title_fullStr P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL
title_full_unstemmed P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL
title_short P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL
title_sort p379: ponatinib and blinatumomab in relapsed/refractory philadelphia-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast phase: subgroup analysis from a phase ii trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428366/
http://dx.doi.org/10.1097/01.HS9.0000968428.69134.08
work_keys_str_mv AT haddadfadi p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT jabbourelias p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT zoghbimarianne p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT shortnicholas p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT nasnascedric p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT nasrlewis p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT macaronwalid p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT jainnitin p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT huangxuelin p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT montalbanbravoguillermo p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT kadiatapan p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT davernaval p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT chienkelly p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT alvaradoyesid p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT garciamaneroguillermo p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT issaghayas p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT kwarimonica p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT delumparicardo p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT mayorejiroghene p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT deenwuliamatu p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT thankachanjennifer p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT loisellechristopher p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT riverajuan p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT miltonanna p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT wallerlourdes p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT banksglenda p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT garrisrebecca p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT ravandifarhad p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial
AT kantarjianhagop p379ponatinibandblinatumomabinrelapsedrefractoryphiladelphiapositiveacutelymphoblasticleukemiaorchronicmyeloidleukemiainlymphoidblastphasesubgroupanalysisfromaphaseiitrial